Literature DB >> 10587234

Dosimetric characterization of a new design 103 palladium brachytherapy source.

R E Wallace1, J J Fan.   

Abstract

Low-energy gamma emitting isotopes encapsulated for permanent implant are in routine use in the treatment of prostate cancer. New source designs require full dosimetric analysis and calibration standardization before responsible clinical application. The results of one such experimental measurement and analysis are here reported for a new design of 103palladium source, model MED3633 (North American Scientific, Inc.). By AAMP Task Group #43 recommendations, the reference material for brachytherapy dosimetry is liquid water. The dose measurements were made using standard methods employing thermoluminescent dosimeters in a water equivalent plastic phantom. Precision machined bores in the phantom located dosimeters and source(s) in a reproducible fixed geometry providing for transverse-axis and angular dose profiles over a range of distances from 0.17 to 7 cm. The data were analyzed in terms of parameters recommended by AAPM TG43. The dose-rate constant, lambda, was evaluated with reference to a 60 cobalt standard, accounting for response variation with isotope energy spectrum. The radial dose function, g(r), the anisotropy function, F(r, theta), the anisotropy factor, phi,un(r), and the point-source approximation anisotropy constant, phi(un), were derived from one- and two-dimensional dose distribution data measured in the phantom, accounting for finite dosimeter volume and with attention to interchip effects. The results are compared to TG43 and other existing data for 103Pd sources. The new source is comparable to the model 200 103Pd source design, demonstrating equivalent radial dose function, g(r). The dose surrounding a MED3633 source may be slightly more isotropic than for the model 200 source. The air-kerma strength of the MED3633 source used in this study was provided by the manufacturer and is traceable to the NIST 1999 standard. The evaluated dose-rate constant, lambda, with NIST traceable strength calibration is lower than that of the model 200 source, with that manufacturer's strength calibration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587234     DOI: 10.1118/1.598765

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  5 in total

1.  Clinical application and validation of an iterative forward projection matching algorithm for permanent brachytherapy seed localization from conebeam-CT x-ray projections.

Authors:  Damodar Pokhrel; Martin J Murphy; Dorin A Todor; Elisabeth Weiss; Jeffrey F Williamson
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

2.  CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy.

Authors:  Jun Jie Wang; Hui Shu Yuan; Jin Na Li; Yu Liang Jiang; Su Qing Tian; Rui Jie Yang
Journal:  Med Oncol       Date:  2009-05-05       Impact factor: 3.064

3.  Thermoluminescent and Monte Carlo dosimetry of IR06-103Pd brachytherapy source.

Authors:  Pooneh Saidi; Mahdi Sadeghi; S Hamed Hosseini; Claudio Tenreiro
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

4.  Dosimetric parameters of three new solid core I-125 brachytherapy sources.

Authors:  Timothy D Solberg; John J DeMarco; Geoffrey Hugo; Robert E Wallace
Journal:  J Appl Clin Med Phys       Date:  2002       Impact factor: 2.102

5.  Cylindrical coordinate based TG-43U1 parameters for dose calculation around elongated brachytherapy sources.

Authors:  Shahid B Awan; Sharifeh A Dini; Manzoor Hussain; David Soleimani-Meigooni; Ali S Meigooni
Journal:  J Appl Clin Med Phys       Date:  2008-04-16       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.